Cempra announces notification of patent allowance for Taksta dose formulation

theflyonthewall.com

Cempra announced that the United States Patent and Trademark Office issued U.S. Patent No. 8,450,300 on May 28, 2013 with claims directed to the company's novel loading dose regimen for Taksta. The patent, entitled "Fusidic Acid Dosing Regimens for Treatment of Bacterial Infections," provides protection until 2029, excluding possible patent term extensions.

View Comments